ReviewFrontiers in immunology2026
NLRP3 inflammasome in cardiovascular diseases: molecular mechanisms and advances in targeted drug research.
Tianqing Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it